Moderate to high expression (++/+++) of cyclin D1 in cancer cells predicted an improved postoperative prognosis of RCC when compared with that of negative or weak expression (−/+) (P=0.015; Kaplan-Meier analysis and the log-rank test; Fig. 1B). This evidence concerns the gene CCND1 and cancer.